AJ

Anju Johny

Active Director Director DIN 11145004
DIN 11145004 First appointment Jun 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Anju Johny

Data last updated:

Anju Johny is a Director at Bhumika Vedics Private Limited (since 2025) and Designated Partner at Cosmayur Pharmaceuticals Llp (since 2025). The companies operate in Pharma.

DIN 11145004
Primary Designation Director
Industry Pharma
First Appointment 09 Jun 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bhumika Vedics Private Limited U21003KL2025PTC097712
Director07 Oct 20252025Active
Designated Partner09 Jun 20252025Active

Board colleagues of Anju Johny

NameDINCompanyDesignation
Robin11145003Bhumika Vedics Private Limited , Cosmayur Pharmaceuticals LlpDirector

Directorship timeline

Open interactive timeline →
Bhumika Vedics Private Limited
Cosmayur Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Anju Johny

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anju Johny

Anju Johny currently holds 2 directorships: Bhumika Vedics Private Limited (Director, since 07 Oct 2025); Cosmayur Pharmaceuticals Llp (Designated Partner, since 09 Jun 2025).

Anju Johny was first appointed on 09 Jun 2025 as Designated Partner at Cosmayur Pharmaceuticals Llp.

The current boards of Anju Johny's companies include Robin (Bhumika Vedics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available